Adverse event reports electronic submissions expected by spring on limited basis -- FDA.
This article was originally published in The Tan Sheet
Executive Summary
PAPERLESS ADVERSE EVENT REPORT SUBMISSIONS EXPECTED BY SPRING from several companies under an ongoing pilot program of FDA's Adverse Event Reporting System (AERS), FDA Surveillance and Data Processing Branch Chief Bill Calvert said at the Nonprescription Drug Manufacturers Association Research & Scientific Development Conference in Washington, D.C. Nov. 13-14. Calvert's office is overseeing agency efforts to implement the transition from "paper" adverse event reports to electronic reports.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning